Considering the suggested substantial influence of library preparation on high-throughput sequencing studies [40] (
link), [41] (
link), we profiled the miRNA expression in blood samples using microarray analysis. miRNA expression measurements were performed as described previously by using the
Agilent microarray system with the Human miRBase V21 microarrays [36] (
link), [42] (
link), containing 2549 mature human miRNAs. In short, RNA was dephosphorylated and then labeled with Cy3-pCp. Labeled RNA samples were hybridized to the arrays for 20 h at 55 °C. After washing and drying, arrays were scanned in an
Agilent microarray scanner at 3-µm resolution in double-path mode. Raw expression values were extracted using
Feature Extraction Software (Agilent Technologies, Santa Clara, CA). Altogether, we selected 580 patients from COSYCONET. For 534 samples, both, the RNA extraction and microarray measurement yielded high-quality results, while 46 samples failed quality control,
i.e., either RNA concentration or RNA integrity number (RIN) value is too low. These samples were excluded prior to further measurement or statistical analysis.
The microarray data are available upon request.
Keller A., Fehlmann T., Ludwig N., Kahraman M., Laufer T., Backes C., Vogelmeier C., Diener C., Biertz F., Herr C., Jörres R.A., Lenhof H.P., Meese E, & Bals R. (2018). Genome-wide MicroRNA Expression Profiles in COPD: Early Predictors for Cancer Development. Genomics, Proteomics & Bioinformatics, 16(3), 162-171.